tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
United Therapeutics (UTHR)
NASDAQ:UTHR
US Market
UTHR
United Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

United Therapeutics (UTHR) Stock News & Sentiment

Compare
621 Followers
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for Pulmonary Fibrosis
Premium
Company Announcements
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for Pulmonary Fibrosis
5d ago
UTHR
United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis
Premium
Company Announcements
United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis
7d ago
UTHR
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: A Potential Game-Changer
Premium
Company Announcements
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: A Potential Game-Changer
11d ago
UTHR
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
Premium
Company Announcements
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
12d ago
UTHR
DDD Lawsuit Alert! Class Action Lawsuit Against 3D Systems Corporation
Premium
Market News
DDD Lawsuit Alert! Class Action Lawsuit Against 3D Systems Corporation
13d ago
DDD
UTHR
United Therapeutics Launches $1 Billion Share Buyback
Premium
Company Announcements
United Therapeutics Launches $1 Billion Share Buyback
18d ago
8K
UTHR
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
Premium
Company Announcements
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
18d ago
UTHR
More UTHR News >

UTHR News on the Web

Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?
Zacks
Neutral
United Therapeutics Launches $1 Billion Share Buyback
TipRanks News
Neutral
Why United Therapeutics Corporation’s (UTHR) Stock Is Up 5.56%
AAII
Neutral
UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y
Zacks
Neutral
BTIG Sticks to Their Hold Rating for United Therapeutics (UTHR)
TipRanks News
Neutral
Earnings Summary on United Therapeutics
The Motley Fool
Neutral
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
Zacks
Bullish
Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics
Zacks
Neutral

News Score - Last 7 Days

Neutral
UTHR
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is UTHR’s Media Buzz Sentiment?
Currently, no data Available
What is UTHR’s weekly average amount of articles?
Currently, no data Available
What is UTHR’s News Sentiment?
50% of articles about UTHR were positive this week, compared to its sector average of 55%.
    Healthcare Stocks that are Trending in the News
    BWAYBrainsway
    RGTLFArgent Biopharma
    KMDAKamada
    OXBDFOxford BioMedica
    OGIOrganiGram Holdings
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing